Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

An estimated 76.4 million people worldwide meet criteria for alcohol use disorders, and 15.3 million meet criteria for drug use disorders. Given the high rates of addiction and the associated health, economic, and social costs, it is essential to develop a thorough understanding of the impact of substance abuse on mental and physical health outcomes and to identify new treatment approaches for substance use disorders (SUDs). Psychoneuroimmunology is a rapidly expanding, multidisciplinary area of research that may be of particular importance to addiction medicine, as its focus is on the dynamic and complex interactions among behavioral factors, the central nervous system, and the endocrine and immune systems (Ader, 2001). This review, therefore, focuses on: 1) the psychoneuroimmunologic effects of SUDs by substance type and use pattern, and 2) the current and future treatment strategies, including barriers that can impede successful recovery outcomes. Evidence-based psychosocial and pharmacotherapeutic treatments are reviewed. Psychological factors and central nervous system correlates that impact treatment adherence and response are discussed. Several novel therapeutic approaches that are currently under investigation are introduced; translational data from animal and human studies is presented, highlighting immunotherapy as a promising new direction for addiction medicine.

Original languageEnglish (US)
Pages (from-to)289-300
Number of pages12
JournalPharmacology and Therapeutics
Volume139
Issue number2
DOIs
StatePublished - Aug 2013

Fingerprint

Substance-Related Disorders
Central Nervous System
Psychoneuroimmunology
Medicine
Therapeutics
Endocrine System
Immunotherapy
Immune System
Mental Health
Alcohols
Economics
Psychology
Costs and Cost Analysis
Health
Research

Keywords

  • Addiction
  • Drug discovery
  • Inflammation
  • Psychoneuroimmunology
  • Substance use disorders
  • Treatment strategies

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{5a972aad4c0244b7b162ec7ab8b13de9,
title = "Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy",
abstract = "An estimated 76.4 million people worldwide meet criteria for alcohol use disorders, and 15.3 million meet criteria for drug use disorders. Given the high rates of addiction and the associated health, economic, and social costs, it is essential to develop a thorough understanding of the impact of substance abuse on mental and physical health outcomes and to identify new treatment approaches for substance use disorders (SUDs). Psychoneuroimmunology is a rapidly expanding, multidisciplinary area of research that may be of particular importance to addiction medicine, as its focus is on the dynamic and complex interactions among behavioral factors, the central nervous system, and the endocrine and immune systems (Ader, 2001). This review, therefore, focuses on: 1) the psychoneuroimmunologic effects of SUDs by substance type and use pattern, and 2) the current and future treatment strategies, including barriers that can impede successful recovery outcomes. Evidence-based psychosocial and pharmacotherapeutic treatments are reviewed. Psychological factors and central nervous system correlates that impact treatment adherence and response are discussed. Several novel therapeutic approaches that are currently under investigation are introduced; translational data from animal and human studies is presented, highlighting immunotherapy as a promising new direction for addiction medicine.",
keywords = "Addiction, Drug discovery, Inflammation, Psychoneuroimmunology, Substance use disorders, Treatment strategies",
author = "Jennifer Loftis and Marilyn Huckans",
year = "2013",
month = "8",
doi = "10.1016/j.pharmthera.2013.04.011",
language = "English (US)",
volume = "139",
pages = "289--300",
journal = "Pharmacology and Therapeutics",
issn = "0163-7258",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Substance use disorders

T2 - Psychoneuroimmunological mechanisms and new targets for therapy

AU - Loftis, Jennifer

AU - Huckans, Marilyn

PY - 2013/8

Y1 - 2013/8

N2 - An estimated 76.4 million people worldwide meet criteria for alcohol use disorders, and 15.3 million meet criteria for drug use disorders. Given the high rates of addiction and the associated health, economic, and social costs, it is essential to develop a thorough understanding of the impact of substance abuse on mental and physical health outcomes and to identify new treatment approaches for substance use disorders (SUDs). Psychoneuroimmunology is a rapidly expanding, multidisciplinary area of research that may be of particular importance to addiction medicine, as its focus is on the dynamic and complex interactions among behavioral factors, the central nervous system, and the endocrine and immune systems (Ader, 2001). This review, therefore, focuses on: 1) the psychoneuroimmunologic effects of SUDs by substance type and use pattern, and 2) the current and future treatment strategies, including barriers that can impede successful recovery outcomes. Evidence-based psychosocial and pharmacotherapeutic treatments are reviewed. Psychological factors and central nervous system correlates that impact treatment adherence and response are discussed. Several novel therapeutic approaches that are currently under investigation are introduced; translational data from animal and human studies is presented, highlighting immunotherapy as a promising new direction for addiction medicine.

AB - An estimated 76.4 million people worldwide meet criteria for alcohol use disorders, and 15.3 million meet criteria for drug use disorders. Given the high rates of addiction and the associated health, economic, and social costs, it is essential to develop a thorough understanding of the impact of substance abuse on mental and physical health outcomes and to identify new treatment approaches for substance use disorders (SUDs). Psychoneuroimmunology is a rapidly expanding, multidisciplinary area of research that may be of particular importance to addiction medicine, as its focus is on the dynamic and complex interactions among behavioral factors, the central nervous system, and the endocrine and immune systems (Ader, 2001). This review, therefore, focuses on: 1) the psychoneuroimmunologic effects of SUDs by substance type and use pattern, and 2) the current and future treatment strategies, including barriers that can impede successful recovery outcomes. Evidence-based psychosocial and pharmacotherapeutic treatments are reviewed. Psychological factors and central nervous system correlates that impact treatment adherence and response are discussed. Several novel therapeutic approaches that are currently under investigation are introduced; translational data from animal and human studies is presented, highlighting immunotherapy as a promising new direction for addiction medicine.

KW - Addiction

KW - Drug discovery

KW - Inflammation

KW - Psychoneuroimmunology

KW - Substance use disorders

KW - Treatment strategies

UR - http://www.scopus.com/inward/record.url?scp=84879420504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879420504&partnerID=8YFLogxK

U2 - 10.1016/j.pharmthera.2013.04.011

DO - 10.1016/j.pharmthera.2013.04.011

M3 - Article

C2 - 23631821

AN - SCOPUS:84879420504

VL - 139

SP - 289

EP - 300

JO - Pharmacology and Therapeutics

JF - Pharmacology and Therapeutics

SN - 0163-7258

IS - 2

ER -